[DOI] [PubMed] [Google Scholar] 295.Jones M.T
Biopolymers 22, 25772637, doi: 10.1002/bip.360221211 (1983)
Some individuals maintain results with breaks if they've established exceptional lifestyle habits, but this success rate remains below 20% across all weight categories
My doctor chased me for two years, and I was like, No, Im afraid of it
They also stress the value of patient education, enabling individuals to recognize side effects early and understand their part in managing them
FDA-approved semaglutide products Who takes semaglutide There are currently three general indications for GLP-1 RAs: Glycemic management in patients with type 2 diabetes Reducing the risk of major adverse cardiovascular events in patients with type 2 diabetes As a weight loss aid for patients who are obese or overweight with cardiovascular risk factors Semaglutide is one of a number of GLP-1 RAs recommended in the management of type 2 diabetes